Finance

01st December 2017

Biomedical Catalyst round 4: late stage award

Small or medium-sized UK companies can apply for a share of up to £8 million to work on solving healthcare challenges in a clinical setting or a relevant late stage environment.

This is a competition for a late stage award in the Biomedical Catalyst.

The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

The Biomedical Catalyst has 4 types of funding award. These are: feasibility, primer, early stage and late stage. They are designed to help SMEs developing a product or process to provide an innovative solution to a health and care challenge. The scheme supports progression from initial concept through to late stage development.

In Biomedical Catalyst round 4 we have 2 competitions, one focusing on the primer stage award and this one, which is focused on the late stage award. You must submit your project to the competition for the correct award. If you submit for the wrong award your application will be immediately rejected and you will not be able to reapply into this round. You can only submit the same application twice to Innovate UK.

You should have prior credible research on your proposal, including a demonstration of validation in a relevant model system. We welcome applications from any sector or discipline.

Competition opens: Monday 27 November 2017
Competition closes: Wednesday 7 February 2018 12:00pm